News
Our Company
Our Story
Our Vision
CEO Statement
Board of Directors
Management
Advisers & Collaborators
Patients & Families
Alzheimer's Patients
Impact on Society
The Unmet Medical Need
R & D
Alzheimer's Disease
Our Programs
Specific Targeting of Toxic Aβ Oligomers
The AβCC Peptide™ Technology
Investors
Overview
Press Releases
English
Swedish
Presentations
The Share
Largest Shareholders
Share Capital Development
Rights Issue / Företrädesemission 2020
Previous Share Issuances
Analyst Coverage
Financial Reports
English
Swedish
Financial Calendar
Corporate governance
General Meetings
Nomination Committee / Valberedning
Auditor
Articles of Association
Board of Directors
Management
Certified Adviser
IR Contact
Contact
News
Our Company
Our Story
Our Vision
CEO Statement
Board of Directors
Management
Advisers & Collaborators
Patients & Families
Alzheimer's Patients
Impact on Society
The Unmet Medical Need
R & D
Alzheimer's Disease
Our Programs
Specific Targeting of Toxic Aβ Oligomers
The AβCC Peptide™ Technology
Investors
Overview
Press Releases
English
Swedish
Presentations
The Share
Largest Shareholders
Share Capital Development
Rights Issue / Företrädesemission 2020
Previous Share Issuances
Analyst Coverage
Financial Reports
English
Swedish
Financial Calendar
Corporate governance
General Meetings
Nomination Committee / Valberedning
Auditor
Articles of Association
Board of Directors
Management
Certified Adviser
IR Contact
Contact
Home
/
Investors
/
Press releases
/
Subscribe
Overview
Press Releases
English
Swedish
Subscribe
Presentations
The Share
Share Monitor
Largest Shareholders
Share Capital Development
Rights Issue / Företrädesemission 2020
Previous Share Issuances
Analyst Coverage
Financial Reports
English
Swedish
Financial Calendar
Corporate Governance
General Meetings
Nomination Committee / Valberedning
Auditor
Articles of Association
Board of Directors
Management
Certified Adviser
IR Contact
Subscribe
